✦ LIBER ✦

Combined treatment with endothelin- and PAF-antagonists reduces posttransplant lung ischemia/reperfusion injury

✍ Scribed by Uz Stammberger; Giovanni L Carboni; Sven Hillinger; Dieter Schneiter; Walter Weder; Ralph A Schmid

Book ID: 117711048
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 147 KB
Volume: 18
Category: Article
ISSN: 1557-3117
DOI: 10.1016/s1053-2498(99)00039-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synergistic effect of endothelin- and PA

Synergistic effect of endothelin- and PAF antagonists on posttransplant lung ischemia/reperfusion injury

✍ U. Stammberger; G.L. Carboni; S. Hillinger; W. Weder; R.A. Schmid 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 358 KB

Combined Enzymatic and Antioxidative Tre

Combined Enzymatic and Antioxidative Treatment Reduces Ischemia-Reperfusion Injury in Rabbit Skeletal Muscle

✍ Christoph Neumayer; Alexander Fügl; Josef Nanobashvili; Roland Blumer; Andreas P 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 343 KB

Role of PAF receptors during intestinal

Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment

✍ Danielle G Souza; Vanessa Pinho; Adriana C Soares; Takao Shimizu; Satoshi Ishii; 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 179 KB

Donor Treatment With the Lazeroid U74389

Donor Treatment With the Lazeroid U74389G Reduces Ischemia–Reperfusion Injury in a Rat Lung Transplant Model

✍ Bernard Hausen MD; Peter Mueller; Marcus Bahra; Raj Ramsamooj MD; Randall E Morr 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 441 KB

Tezosentan, a novel endothelin receptor

Tezosentan, a novel endothelin receptor antagonist, markedly reduces rat hepatic ischemia and reperfusion injury in three different models

✍ Douglas G. Farmer; Fady Kaldas; Dean Anselmo; Masamichi Katori; Xiu-Da Shen; Cha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB

This study investigated the effects of dual endothelin (ET) receptor blockade in rat models of liver ischemia and reperfusion injury (IRI). Three models of IRI were used: (1) in vivo total hepatic warm ischemia with portal shunting for 60 minutes with control (saline) and treatment groups (15 mg/kg

FR128998 (a PAF receptor antagonist) cou

FR128998 (a PAF receptor antagonist) counters the increased pulmonary vascular resistance associated with ischemia-reperfusion injury in the canine lung

✍ Shigeru Iwazaki; Izumi Takeyoshi; Susumu Ohwada; Yutaka Sunose; Masaaki Aiba; Hi 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 753 KB